| A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection (NCT01223222) | Lytix Biopharma AS | 2010-09-01 |
| Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia (NCT01206335) | Ohr Pharmaceutical Inc. | 2010-09-01 |
| Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients (NCT01103414) | Metabolic Solutions Development Company | 2010-09-01 |
| Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer (NCT00932152) | University of Pittsburgh | 2010-09-01 |
| Metformin in Castration-Resistant Prostate Cancer (NCT01215032) | Massachusetts General Hospital | 2010-09-01 |
| Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe) (NCT01212094) | National Institute of Neurological Disorders and Stroke (NINDS) | 2010-09-01 |
| Building Outcomes With Observation-Based Supervision: An FFT Effectiveness Trial (NCT01614015) | Oregon Research Institute | 2010-09-01 |
| Splinting to Treat Hand Osteoarthritis (NCT01249391) | Imperial College London | 2010-09-01 |
| Evaluation of the Tympanostomy Tube Delivery System (NCT01202578) | Integra LifeSciences Corporation | 2010-09-01 |
| Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women. (NCT01204190) | Bayer | 2010-09-01 |
| Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants (NCT01206946) | American University of Beirut Medical Center | 2010-09-01 |
| Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis (NCT01226147) | Kinki University | 2010-09-01 |
| Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications (NCT01227967) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas (NCT01140737) | Sheffield Teaching Hospitals NHS Foundation Trust | 2010-08-31 |
| Hypofractionated Stereotactic Boost in Prostate Cancer (NCT01596816) | Centre Oscar Lambret | 2010-08-31 |
| An Extension Protocol for Subjects Who Were Previously Enrolled in Other Tivantinib (ARQ 197) Protocols (NCT01178411) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2010-08-31 |
| Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis (NCT01185821) | Novartis Pharmaceuticals | 2010-08-30 |
| A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease (NCT01211977) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2010-08-27 |
| Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma (NCT01142232) | Attaya Suvannasankha | 2010-08-27 |
| Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma (NCT01057121) | National Cancer Institute (NCI) | 2010-08-27 |
| Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer (NCT01174121) | National Cancer Institute (NCI) | 2010-08-26 |
| Afamelanotide in Patients Suffering With Acne Vulgaris (NCT04943159) | Clinuvel Pharmaceuticals Limited | 2010-08-24 |
| Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults (NCT01165242) | GlaxoSmithKline | 2010-08-19 |
| Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma (NCT03388372) | Biotech Pharmaceutical Co., Ltd. | 2010-08-18 |
| Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer (NCT01158222) | Case Comprehensive Cancer Center | 2010-08-18 |
| Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose (NCT01171989) | GlaxoSmithKline | 2010-08-18 |
| GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection (NCT01209078) | GlaxoSmithKline | 2010-08-17 |
| Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload (NCT01186419) | Shire | 2010-08-13 |
| 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in Patients With High-Risk Neuroblastoma (NCT01183429) | Memorial Sloan Kettering Cancer Center | 2010-08-12 |
| Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates (NCT00609154) | Albert Einstein College of Medicine | 2010-08-12 |
| 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow (NCT01183897) | Memorial Sloan Kettering Cancer Center | 2010-08-12 |
| Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer (NCT01084083) | Eastern Cooperative Oncology Group | 2010-08-11 |
| Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses (NCT01540110) | National Cancer Centre, Singapore | 2010-08-11 |
| Efficacy of Delayed Coloanal Anastomosis for Medium and Lower Rectum Cancer Treatment. Phase 2 Clinical Trial (CASCADOR) (NCT01876901) | Institut Bergonié | 2010-08-11 |
| A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma (NCT01153763) | GlaxoSmithKline | 2010-08-09 |
| Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (NCT01189266) | National Cancer Institute (NCI) | 2010-08-09 |
| Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (NCT01175980) | National Cancer Institute (NCI) | 2010-08-06 |
| A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment (NCT01136733) | Eisai Inc. | 2010-08-05 |
| Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma (NCT01152788) | NCIC Clinical Trials Group | 2010-08-05 |
| PF-00489791 For The Treatment Of Raynaud's (NCT01090492) | Pfizer | 2010-08-04 |
| Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee Osteoarthritis (NCT01119898) | Mallinckrodt | 2010-08-02 |
| Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study (NCT01054196) | Weill Medical College of Cornell University | 2010-08-01 |
| Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia (NCT01088984) | Teva Branded Pharmaceutical Products R&D, Inc. | 2010-08-01 |
| Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer (NCT01038752) | Optimum Therapeutics, LLC | 2010-08-01 |
| A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL) (NCT01087151) | Genentech, Inc. | 2010-08-01 |
| Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone (NCT01395784) | New York State Psychiatric Institute | 2010-08-01 |
| Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer (NCT01614938) | Fudan University | 2010-08-01 |
| Trans-Radial Coronary Interventions Using A Sheathless Guiding Catheter (NCT01327365) | University Hospital, Geneva | 2010-08-01 |
| CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma (NCT02258815) | University Children's Hospital Tuebingen | 2010-08-01 |
| Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA) (NCT01181050) | Janssen Research & Development, LLC | 2010-08-01 |
| Effects of Intentional Weight Loss Interventions in Chronic Kidney Disease (NCT01180101) | The Cleveland Clinic | 2010-08-01 |
| Prevention of Nosocomial E. Coli Infections After Placement of an Indwelling Catheter During Pelvic Surgery: an Evaluation of Cranberry Gel Capsules (NCT01114347) | Centre Hospitalier Universitaire de Nīmes | 2010-08-01 |
| Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib (NCT01189435) | Memorial Sloan Kettering Cancer Center | 2010-08-01 |
| Stepped Care in the Treatment of Trichotillomania (NCT01118637) | American University | 2010-08-01 |
| Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim (NCT01182675) | University of California, San Francisco | 2010-08-01 |
| Neurofeedback Treatment of Pain in Persons With Spinal Cord Injury (SCI) (NCT00977041) | University of Washington | 2010-08-01 |
| Randomized Control Trial of Family-Based HIV Prevention for Latinos (NCT01635335) | University of South Florida | 2010-08-01 |
| Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial (NCT01269788) | Tehran University of Medical Sciences | 2010-08-01 |
| Caffeine for Motor Manifestations of Parkinson's Disease (NCT01190735) | Ron Postuma | 2010-08-01 |
| STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer (NCT01167114) | Massachusetts General Hospital | 2010-08-01 |
| Efficacy of an Intranasal Testosterone Product (NCT01252745) | Acerus Pharmaceuticals Corporation | 2010-08-01 |
| Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE (NCT01187212) | Asan Medical Center | 2010-08-01 |
| Treatment of Knee Arthrosis With Platelet-derived Growth Factors vs. Hyaluronic Acid. (NCT02958761) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2010-08-01 |
| Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors (NCT02150525) | Ohio State University Comprehensive Cancer Center | 2010-08-01 |
| Usability of Ringed Polytetrafluoroethylene Graft for Venous Vascular Reconstruction of Living Donor Liver Transplantation (NCT01205802) | Asan Medical Center | 2010-08-01 |
| Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection as Adjunctive Therapy in Subjects With Internal Carotid Artery Hypoperfusion (NCT01192581) | Xijing Hospital | 2010-08-01 |
| The Impact of Patient Positioning and Use of Belly Board on Small Bowel and Urinary Bladder Volume Irradiated in Patients Receiving Radiotherapy for Rectal Cancer: A Prospective Phase II Study (NCT01142713) | Tel-Aviv Sourasky Medical Center | 2010-08-01 |
| Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML) (NCT01160354) | M.D. Anderson Cancer Center | 2010-08-01 |
| Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration (NCT01122511) | Allergan | 2010-08-01 |
| Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic Anemia (NCT01182662) | Shandong University | 2010-08-01 |
| A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's (NCT01148498) | Eli Lilly and Company | 2010-08-01 |
| Acne Treatment With Active Oplon's Patches (NCT01180543) | Oplon-Pure Science Ltd. | 2010-08-01 |
| Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer (NCT01200810) | National Cancer Institute (NCI) | 2010-08-01 |
| Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients (NCT01176747) | Chiesi Farmaceutici S.p.A. | 2010-08-01 |
| OIT and Xolair® (Omalizumab) in Cow's Milk Allergy (NCT01157117) | Hugh A Sampson, MD | 2010-08-01 |
| The Effect of Combined Ephedrine and Lidocaine Pretreatment on Pain and Hemodynamic Changes Due to Propofol Injection (NCT01186549) | Qazvin University Of Medical Sciences | 2010-08-01 |
| Assessment of Bioimpedance and Vitamin D and LV Mass in PD Patients (FLUID Study) (NCT01045980) | St. Joseph's Healthcare Hamilton | 2010-08-01 |
| Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) (NCT01199575) | University of California, San Diego | 2010-08-01 |
| Low Vision Intervention Trial II (LOVIT II) (NCT00958360) | VA Office of Research and Development | 2010-08-01 |
| Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma (NCT01191034) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2010-08-01 |
| Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men (NCT01200862) | Mereo BioPharma | 2010-08-01 |
| Salvage Docetaxel for Pretreated Urothelial Cancer (NCT01711112) | Samsung Medical Center | 2010-08-01 |
| Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors (NCT01374841) | European Institute of Oncology | 2010-08-01 |
| Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis (NCT01237119) | University of Birmingham | 2010-08-01 |
| A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures (NCT01185028) | National Institutes of Health Clinical Center (CC) | 2010-08-01 |
| Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours (NCT01161316) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2010-08-01 |
| Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL) (NCT01191749) | M.D. Anderson Cancer Center | 2010-08-01 |
| Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis (NCT01191996) | Innate Immunotherapeutics | 2010-08-01 |
| Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation (NCT01116232) | Barbara Ann Karmanos Cancer Institute | 2010-08-01 |
| Abbreviated R-CHOP in Completely Excised Stage I or II DLBCL (NCT01279902) | Asan Medical Center | 2010-08-01 |
| Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy (NCT02423707) | Karolinska Institutet | 2010-08-01 |
| The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography (NCT01824056) | Chang Gung Memorial Hospital | 2010-08-01 |
| A Study of Ramucirumab or Icrucumab in Colorectal Cancer (NCT01111604) | Eli Lilly and Company | 2010-08-01 |
| HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment (NCT01383837) | New York State Psychiatric Institute | 2010-08-01 |
| Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV) (NCT01201057) | Starpharma Pty Ltd | 2010-08-01 |
| Tezosentan in Pulmonary Arterial Hypertension (NCT01077297) | Idorsia Pharmaceuticals Ltd. | 2010-08-01 |
| Dil Mil (Hearts Together) (NCT01337778) | RTI International | 2010-08-01 |
| Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT01145508) | National Cancer Institute (NCI) | 2010-08-01 |
| A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia (NCT01187017) | National Heart, Lung, and Blood Institute (NHLBI) | 2010-08-01 |
| Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer (NCT01231581) | GlaxoSmithKline | 2010-08-01 |